BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Novocure Announces 11 Presentations on Tumor Treating Fields in Multiple Solid Tumor Types at the American Society for Radiation Oncology 2022 Annual Meeting

  Novocure announced 11 poster presentations on Tumor Treating Fields will be featured at the American Society for Radiation Oncology 2022 Annual Meeting from Oct. 23 to Oct. 26 in San Antonio, Texas.

  October 21, 2022

   · 

  7 min read
• Pharm Country

  Almirall PROSES study demonstrates appropriate acne treatment decreases the burden of impact on acne sufferers’ social and emotional wellbeing

  Almirall, LLC, a global biopharmaceutical company focused on skin health, is excited to announce the release of its privately funded PROSES study at this year’s Fall Clinical Dermatology Conference® in Las Vegas, Nevada, October 20-23, 2022.

  October 21, 2022

   · 

  10 min read
• Business

  Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast

  Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2022 financial results before market opening on Thursday, November 3, 2022.

  October 21, 2022

   · 

  2 min read
• Business

  Syneos Health Schedules Third Quarter 2022 Earnings Call for Friday, November 4, 2022

  Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2022 financial results on Friday, November 4, 2022, prior to its earnings call at 8:00 a.m. ET.

  October 21, 2022

   · 

  1 min read